Related Experiment Video

Updated: Aug 20, 2026

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on: September 8, 2017

Two regimens of docetaxel for metastatic breast cancer

Andrew D Seidman, Larry Norton

    Current Oncology Reports
    |December 22, 2004
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers
    06:02

    Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers

    Published on: February 20, 2017

    Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
    08:57

    Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

    Published on: October 5, 2017

    Related Experiment Videos

    Last Updated: Aug 20, 2026

    Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
    06:44

    Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

    Published on: September 8, 2017

    Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers
    06:02

    Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers

    Published on: February 20, 2017

    Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
    08:57

    Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

    Published on: October 5, 2017

    Related Concept Videos

    Drugs that Stabilize Microtubules01:15

    Drugs that Stabilize Microtubules

    Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...

    Articles linked to this work by shared authors, journal, and citation graph.

    Adaptive and sequential cancer therapies emerge from treatment schedule optimization.

    Research square·2026

    Cancer During Pregnancy: Navigating Clinical and Research Challenges.

    Current oncology (Toronto, Ont.)·2026

    Homologous recombination deficiency and hemizygosity drive resistance in breast cancer.

    Nature·2026

    Monitoring of circulating tumor DNA in patients with stage II-III breast cancer treated with neoadjuvant chemotherapy.

    NPJ breast cancer·2026

    Predictors of response to neoadjuvant chemo-immunotherapy in metaplastic triple-negative breast cancer.

    NPJ breast cancer·2025

    Proton Craniospinal Irradiation for Patients With Leptomeningeal Metastasis: A Randomized Clinical Trial.

    JAMA oncology·2025

    Next-Generation Sequencing in Translational Sarcoma Research: Biological Insights and Emerging Directions.

    Current oncology reports·2026

    What are the Unmet Needs in Managing Digestive Neuroendocrine Carcinomas?

    Current oncology reports·2026

    Recent Advances in Surveillance Strategies for Nasopharyngeal Carcinoma.

    Current oncology reports·2026

    Gender, Sex and Other Factors in the Development of Neuroendocrine Neoplasms.

    Current oncology reports·2026

    The Oral Microbiome in Oral Cavity Cancer: Mechanisms of Carcinogenesis, Biomarkers, and Therapeutic Implications.

    Current oncology reports·2026

    Navigating Antibody-Drug Conjugate Sequencing in Gastric Cancer: Cross-Resistance Biology, Target Switching, and Decision-Making Frameworks for the Post-Progression Landscape.

    Current oncology reports·2026

    Immune Cell Engager Therapy for Brain Cancer.

    Neuro-oncology·2026

    Gut microbiota-mediated dietary lignans metabolism drives accumulation of N,N-dimethylsphingosine and sensitizes triple-negative breast cancer to paclitaxel.

    Food & function·2026

    Ocular Microcystic Adnexal Carcinoma With High-Grade Features: A Case Report With Orbital Exenteration.

    International journal of surgical pathology·2026

    Effect of photobiomodulation therapy on regulating reparative processes of chronic wounds at the inflammation stage.

    Biomedica : revista del Instituto Nacional de Salud·2026

    Doxorubicin and 4-Hydroperoxycyclophosphamide Alter Mitochondrial Dynamics and miR-34 Expression in Spermatogonia and Spermatocytes In Vitro.

    Basic & clinical pharmacology & toxicology·2026

    Neurotoxicity and cognitive outcomes in modern therapies for primary central nervous system lymphoma.

    Current opinion in oncology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us